In vivo effect of two first-line ART regimens on inflammatory mediators in male HIV patients

Adjudicated Morbidity and Mortality Outcomes by Age among Individuals with HIV Infection on Suppressive Antiretroviral Therapy

(2014) Christopher J. Miller et al.   PLoS One

Platelet activating factor levels and metabolism in tangier disease: a case study

(2012) Vana Kolovou et al.   Lipids in Health and Disease

Effects of HAART on Platelet-Activating Factor Metabolism in Naive HIV-Infected Patients I: Study of the Tenofovir-DF/Emtricitabine/Efavirenz HAART Regimen

(2011) Maria Chini et al.   AIDS RESEARCH AND HUMAN RETROVIRUSES

Platelet-Activating Factor and Its Basic Metabolic Enzymes in Blood of Naive HIV-Infected Patients

(2011) Alexandros B. Tsoupras et al.   ANGIOLOGY

Early changes in inflammatory and pro-thrombotic biomarkers in patients initiating antiretroviral therapy with abacavir or tenofovir

(2011) Authors: Sergio Padilla et al.   BMC INFECTIOUS DISEASES

PAF and its metabolic enzymes in healthy volunteers: Interrelations and correlations with basic characteristics

(2011) Paraskevi Detopoulou et al.   PROSTAGLANDINS & OTHER LIPID MEDIATORS

Inflammatory biomarkers and abacavir use in the Womenʼs Interagency HIV Study and the Multicenter AIDS Cohort Study

(2010) Frank J Palella et al.   AIDS

Lipoprotein-associated phospholipase A2 as a biomarker of coronary heart disease and a therapeutic target

(2009) Chris J Packard   CURRENT OPINION IN CARDIOLOGY

Development of a platelet-activating factor antagonist for HIV-1 associated neurocognitive disorders

(2009) Dawn Eggert et al.   JOURNAL OF NEUROIMMUNOLOGY

The role of HIV in serious diseases other than AIDS

(2008) Andrew N Phillips et al.   AIDS

European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of HIV-infected adults

(2008) N Clumeck et al.   HIV MEDICINE